QA: Avidity Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001599901_2023_Avidity_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0001599901, Avidity Biosciences Inc.

  xvar xval
0 AssetsCurrent 622,942,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,254,000
3 remainder_Assets 9,604,000
4 LiabilitiesCurrent 51,908,000
5 LiabilitiesNoncurrent 8,817,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 37,733,000
9 ResearchAndDevelopmentExpense 150,404,000
10 remainder_Expenses 0
11 remainder_Revenues 9,224,000
12 remainder_NetIncome 4,918,000
13 remainder_ComprehensiveNetIncome -2,511,000
  yvar yval
0 Assets 638,800,000
1 Liabilities 60,725,000
2 Expenses 188,137,000
3 Revenues 9,224,000
4 StockholdersEquity 578,075,000
5 NetIncome -173,995,000
6 ComprehensiveNetIncome -175,250,500
7 BaseVar 452,157,500
8 EconomicCapitalRatio 2.34

Edgar->Model Mapping

Feature Distribution

Change over Time